CAM
LYRA

Close Asset Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Close Asset Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 209
2022
Q3 		$0 Hold
1
– – ﹤0.01% 192
2022
Q2 		$0 Sell
1
-139
-99% -$37.8K ﹤0.01% 207
2022
Q1 		$30K Hold
140
– – ﹤0.01% 144
2021
Q4 		$30K Hold
140
– – ﹤0.01% 144
2021
Q3 		$64K Buy
+140
New +$52.9K ﹤0.01% 109

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Close Asset Management's LYRA Position: Q4 2022 in Review

Close Asset Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2022, closing a stake of 1 share.

Close Asset Management first reported a position in LYRA in Q3 2021 and held it in 5 quarters. The position peaked at $64K in Q3 2021. 35 funds tracked by Wall St. Rank hold LYRA as of Q4 2022.

  • Close Asset Management reported no remaining LYRA THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Close Asset Management sold 1 LYRA THERAPEUTICS INC share in Q4 2022.
  • Close Asset Management first reported a position in LYRA THERAPEUTICS INC in Q3 2021 and held it in 5 quarters.
  • Close Asset Management's LYRA THERAPEUTICS INC position peaked at $64K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2022.

Based on Close Asset Management's 13F filing for Q4 2022, filed 27 Jan 2023.